Thymoma and autoimmunity

Cellular and Molecular Immunology

Volumn 8, Issue 3, 2011, Pages 199-202

  Shelly, Shahar ^a   Agmon Levin, Nancy ^a,b   Altman, Arie ^a,b   Shoenfeld, Yehuda ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

autoimmune diseases; autoimmunity; self tolerance; thymoma; thymus

Indexed keywords

AUTOIMMUNITY; DISEASE ASSOCIATION; EPITHELIUM TUMOR; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; INAPPROPRIATE VASOPRESSIN SECRETION; MYASTHENIA GRAVIS; PEMPHIGUS VULGARIS; PERNICIOUS ANEMIA; PRE T LYMPHOCYTE; PURE RED CELL ANEMIA; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMOMA;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; CELL DIFFERENTIATION; HUMANS; SELF TOLERANCE; T-LYMPHOCYTES; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 79955650335     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.74     Document Type: Review

References (45)

1. Thomas CR, Wright CD, Loehrer PJ. Thymoma: stateof theart. JClin Oncol 1999; 17: 2280-2289.
2. Hoffacker V, Schultz A, Tiesinga JJ, Gold R, Schalke B, Nix W et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood 2000; 96: 3872-3879.
3. Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J et al. WHO histologicclassification isa prognostic indicator inthymoma. Ann Thorac Surg 2004; 77: 1183-1188. (Pubitemid 38452343)
4. Kondo K. Optimal therapy for thymoma. J Med Invest 2008; 55: 17-28. (Pubitemid 351643589)
5. Lucchi M, Basolo F, Ribechini A, Ambrogi MC, Bencivelli S, Fontanini G et al. Thymomas: clinical-pathological correlations. J Cardiovasc Surg (Torino) 2006; 47: 89-93.
6. Grob D, Brunner N, Namba T, Pagala M. Lifetimecourseof myastheniagravis. Muscle Nerve 2008; 37: 141-149.
7. Gomez AM, vanden Broeck J, Vrolix K, Janssen SP, Lemmens MA, vander Esch E et al. Antibody effector mechanisms in myasthenia gravis\pathogenesis at the neuromuscular junction. Autoimmunity 2010; 43: 353-370.
8. Soltys J, Gong B, Kaminski HJ, Zhou Y, Kusner LL. Extraocular musclesusceptibility to myasthenia gravis: unique immunological environment? Ann NY Acad Sci 2008; 1132: 220-224. (Pubitemid 351841377)
9. Okumura M, Fujii Y, Shiono H, Inoue M, Minami M, Utsumi T et al. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Gen Thorac Cardiovasc Surg 2008; 56: 143-150. (Pubitemid 351514680)
10. Mygland A, Vincent A, Newsom-Davis J, Kaminski H, Zorzato F, Agius M et al. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol 2000; 57: 527-531. (Pubitemid 30212127)
11. Ghosh JB, Roy M, Peters T. Thymoma associated with myastheniagravis in infancy. Indian J Pediatr 2009; 76: 1057-1058.
12. + regulatory T cells through IL-7 signaling pathway. JImmunol 2009; 183: 6135-6144.
13. Shere Y, Bar-Dayan Y, Shoenfeld Y. Tymoma thymic hyperplasia, thymectomy and autoimmunediseases. Int JOncol 1997; 10: 939-943. (Pubitemid 27210159)
14. Boonen A, Rennenberg R, van der Linden S. Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature. Rheumatology (Oxford) 2000; 39: 1044-1046.
15. Souadjian JV, Enriquez P, Silverstein MN, Pepin JM. The spectrum of diseases associated with thymoma. Coincidence or syndrome? Arch Intern Med 1974; 134: 374-379.
16. Rosman A, Atsumi T, Khamashta MA, Ames PR, Hughes GR. Developmentof systemic lupuserythematosusafterchemotherapyand radiotherapyfor malignantthymoma. Br J Rheumatol 1995; 34: 1175-1176.
17. Zandman-Goddard G, Lorber M, Shoenfeld Y. Systemic lupus erythematosus and thymoma\adouble-edgedsword. Int Arch Allergy Immunol 1995; 108: 99-102.
18. Zhang L, Dong J, Leng XM, Zeng XF. Ameta-analysisofthymoma- associatedsystemic lupuserythematosusfrom 1975-2008worldwide. Zhonghua Nei Ke Za Zhi 2009; 48: 643-646. Chinese.
19. Park MJ, Kim YA, Lee SS, Kim BC, Kim MK, Cho KH. Appearance of systemic lupus erythematosus in patients with myasthenia gravis following thymectomy: two case reports. JKorean Med Sci 2004; 19: 134-136.
20. Mevorach D, Perrot S, Buchanan NM, Khamashta M, Laoussadi S, Hughes GR et al. Appearance of systemic lupus erythematosus afterthymectomy: four case reports and reviewofthe literature. Lupus 1995; 4: 33-37.
21. Bozzolo E, Bellone M, Quaroni N, Voci C, Sabbadini MG. Thymoma associated with systemic lupuserythematosusand immunologicabnormalities. Lupus 2000; 9: 151-154. (Pubitemid 30171115)
22. Gaman A, Gaman G, Bold A. Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors. Rom J Morphol Embryol 2009; 50: 669-674.
23. Thompson CA, Steensma DP. Purered cell aplasiaassociatedwiththymoma: clinical insightsfrom a 50-yearsingle-institution experience. Br JHaematol 2006; 135: 405-407. (Pubitemid 44484851)
24. Galesic K, Krizanac S, Vrkljan M, Ljubanovic D. Syndrome of inappropriate secretion of antidiuretic hormone dueto malignantthymoma. Nephron 2002; 91: 752-754. (Pubitemid 34914083)
25. Donadio AC, Dragnev KH, Schwartz GK. Thymoma associated with syndrome of inappropriate antidiuretic hormone secretion and myasthenia gravis. South Med J 1998; 91: 278-279. (Pubitemid 28227596)
26. Mutasim DF. Autoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosisand management. Drugs Aging 2010; 27: 1-19.
27. Souteyrand P, Berthier-Boachon M, Thivolet J. Pemphigusandthymoma: reviewand etiopathogenesis (author's transl). Ann Dermatol Venereol 1981; 108: 457-467. French.
28. Barbetakis N, Samanidis G, Paliouras D, Boukovinas I, Asteriou C, Stergiou E et al. Paraneoplastic pemphigus regression after thymoma resection. World J Surg Oncol 2008; 6: 83.
29. Davila DG, Ryan DH. Thymoma, hypogammaglobulinemia, and pernicious anemia. South Med J 1986; 79: 904-906.
30. Elliott GB, Hill M, Howard DL. Whipple's disease associated with benign thymoma. Can Med Assoc J 1961; 85: 1340-1344.
31. de Keyzer K, Peeters P, Verhelst C, Dendooven A, Vonck A, Vanholder R. Autoimmune haemolytic anaemia associated with a thymoma: case report and review of the literature. Acta Clin Belg 2009; 64: 447-451.
32. Hammoud K, Kandimala G, Warnack W, Vernino S. Multifocal paraneoplastic cortical encephalitisassociatedwith myastheniagravisandthymoma. Arch Neurol 2009; 66: 1407-1409.
33. Arbib F, Bejui F, Bouvier R, Ninet J, Guerin JC. Thymoma and primary Gougerot-Sjogren syndrome progressing to severe bronchiolitis. Rev Mal Respir 1993; 10: 465-467. French.
34. Yoshida H, Matsuda S, Abe R, Kimura H, Shichishima T, Tanaka T et al. Sjogren's syndromeassociated witha benignthymictumor: report of acasewithwidespectrum of clinical feature (author's transl). Nippon Ketsueki Gakkai Zasshi 1980; 43: 834-841. Japanese.
35. Lee BW, Ihm SH, Shin HS, Yoo HJ. Malignantthymoma associatedwith myasthenia gravis, Graves' disease, and SIADH. Intern Med 2008; 47: 1009-1012.
36. Kabelitz D, Schreiber S. Autoimmunity. Physiological control mechanisms and pathwaystoautoimmunedisease. Internist(Berl)2009; 50: 267-275. German.
37. Wang L. Adaptive Treg generation by DCs and their functional analysis. Methods Mol Biol 2010; 595: 403-412.
38. Wing K, Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 2010; 11: 7-13.
39. Chilosi M, Iannucci A, Menestrina F, Lestani M, Scarpa A, Bonetti F et al. Immunohistochemical evidence of active thymocyte proliferation in thymoma. Its possible role in the pathogenesis of autoimmune diseases. Am J Pathol 1987; 128: 464-470. (Pubitemid 17139897)
40. Shoenfeld Y, Lorber M, Yucel T, Yazici H. Primary antiphospholipid syndrome emerging following thymectomy for myasthenia gravis: additional evidence for the kaleidoscope of autoimmunity. Lupus 1997; 6: 474-476. (Pubitemid 27395387)
41. Vincent A, Willcox N. The roleof T-cells inthe initiation of autoantibody responses in thymoma patients. Pathol Res Pract 1999; 195: 535-540. (Pubitemid 29405756)
42. Tokunaga T, Hayashi A, Kadota Y, Shiono H, Inoue M, Sawabata N et al. Regulationof Th-POK and Runx3 in T cell development in human thymoma. Autoimmunity 2009; 42: 653-660.
43. Kyewski BA. Thymic dendritic cells present blood-borne antigens to medullary thymocytes in vivo: a possible role in the generation of the T-cell repertoire. Haematol Blood Transfus 1985; 29: 486-491.
44. Theofilopoulos AN, Dummer W, Kono DH. T cell homeostasis and systemic autoimmunity. J Clin Invest 2001; 108: 335-340. (Pubitemid 32730776)
45. Machens A, Loliger C, Pichlmeier U, Emskotter T, Busch C, Izbicki JR. Correlation of thymic pathologywith HLA in myasthenia gravis. Clin Immunol 1999; 91: 296-301 (Pubitemid 29250215)